Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd

Group 1 - A securities class action lawsuit has been filed against RxSight, Inc. on behalf of investors who purchased its securities [1] - The class period for the lawsuit is from November 7, 2024, to July 8, 2025, and it alleges securities fraud and unlawful business practices [6] - RxSight reported significant declines in sales of its Light Delivery Device and lower usage of light adjustable intraocular lenses, leading to an overall revenue shortfall [6] Group 2 - The company cut its full year 2025 guidance by approximately $42.5 million due to "adoption challenges" affecting sales [6] - Following the negative news, RxSight's stock price dropped by $4.84, a decrease of 37.84%, closing at $7.95 per share on July 9, 2025 [6] - The lead plaintiff deadline for the lawsuit is September 22, 2025, encouraging affected investors to contact the law firm for more information [6]